Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANECO: Hemoglobin Drop and SVR in Chronic Hepatitis C
NCT01585324Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2012
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV), sponsored by Roche. Started Jan 2012; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01585324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585324.